Field dossier · from the corpus
Chemotherapy
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Non-small cell lung cancer: current treatment and future advances
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics
Clinical significance of tumor-infiltrating lymphocytes in breast cancer
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients